• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM

CHIMERIC THERAPEUTICS LIMITED - Charts / Financials

0.00% ! 0.4¢
Market Cap $8.060M  !
Healthcare Biotechnology
Add to My Watchlist

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase 1B clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of NK and CAR NK assets with plans for Phase 1B clinical trials in solid tumors and blood cancers.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day
Open 0.5¢   Day High 0.5¢   Day Low 0.4¢
Daily Volume 3919259
Bids   Sellers
Number Price Volume   Number Price Volume
26 0.4¢ 21936206   27 0.5¢ 24685267

Directors & Senior Management

Mr. Paul Hopper Executive Chairman of the Board, Founder
Mr. Phillip Hains Chief Financial Officer, Joint Company Secretary, Director
Dr. Rebecca Mcqualter Chief Operating Officer
Dr. Eliot Bourk Chief Business Officer
Dr. Jason B. Litten Chief Medical Officer
Mr. Nathan Jong Joint Company Secretary
Dr. Lesley Russell Non-Executive Director
Mr. Eric M. Sullivan Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $15.69K 3.919M

Buyers (Bids)

No. Vol. Price($)
26 21936206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 24685267 27
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?

Top Stories

HotCopper Highlights, Week 24: Israel boosts Energy; Meeka eyes production & Mag7 back

Good Afternoon and welcome to HotCopper Highlights for Week 24 of the year, I’m Jon Davidson. In this segment we look at some of the...
Clinuvel shares dip, even as CEO comes back from temp leave After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...
Zip's stunning comeback: Is this the start of a $14 revival? Just when the market had written it off… Zip Co (ASX: ZIP) has come roaring back to life. The Buy Now, Pay Later company stunned investors last Wednesday with a 15% surge in its share price soon after upgrading its full-year earnings forecast to at least $160 million @ up from $153 million...
Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing) Welcome to this week’s HotCopperWire, our market watch podcast!Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through all the week’s biggest news headlines @ and what they mean for Aussie investors.In this Week ...
'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits Advance Metals (ASX:AVM) has started its maiden drilling at the Yoquivo Silver-Gold Project in Mexico with a bang...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.